Home
Transactions

Topic: Transactions

Rise of AI continues to re-write life sciences IP strategies in 2022

A spate of pharma-high tech innovation partnerships have dominated opening days of the year

Panasonic closes patent transactions with major LED and OLED players

Lighting firm Signify and panel-maker Samsung Display each acquired portfolios from one of Japan’s leading IP dealmakers last month

Patent marketplace has been the unsung hero of the remote work era

Saturday Opinion: Technology solutions that have helped the world through the pandemic would look very different absent a sophisticated IP licensing ecosystem, argues Dolby GC Andy Sherman

Latest content

Ericsson turns in strong licensing quarter with Apple renewal looming

Continued impact of Samsung deal pushes Swedish company’s royalty take near $300 million – but executives warn upcoming re-negotiations could produce temporary disruption again

19 October 2021

Patent assignment activity of major semiconductor vendors remains robust

Co-published - IP transfers in the sector happen for many reasons but one of the primary ones is to create additional value from the assets concerned

18 October 2021

Chinese semiconductor upstart steps into IP spotlight in patent licence deal with Xperi

Yangtze Memory Technologies Co, based in Wuhan, is just five years old but has emerged as the country’s memory chip champion

14 October 2021

Former Nortel and BlackBerry patents land with smartphone maker Honor

Transaction marks first outside patent acquisition since company was spun out from Huawei last year

13 October 2021

IPBC Europe in Dublin brought patent value issues to the fore

Saturday Opinion: A memorable two days in the Irish capital showed definitively that face-to-face trumps video and allowed for some detailed debate on key topics

09 October 2021

Four IP takeaways from Merck’s $11.5 billion Acceleron acquisition

Merck has struck the biggest life sciences M&A deal of 2021 so far. Here are the four key IP-related takeaways.

07 October 2021

Purchase of Alphabet rights marks rare patent acquisition for Japan’s Softbank

Assignment records show that despite parent company’s vast backing for startups, Softbank Corp and its affiliates have not often come into the possession of significant third-party portfolios

04 October 2021

Biopharma IP licensors are getting more money - and earlier - for their innovations

M&A may be stagnant, but innovators are receiving larger upfront payments for partnership agreements

01 October 2021

New Chinese iPhone manufacturer inks patent licence deal with 3M as it continues to face US legal threats

Luxshare has pursued Chinese legal challenges and gotten more involved in dealmaking in response to its first serious patent litigation threat, filed in the US last year

30 September 2021

Transparency around patent ownership is good, market says, but new proposal to mandate it has flaws

Experts embrace the Leahy/Tillis bill’s aims, but warn it could create unwelcome, new overhead costs and administrative burdens

29 September 2021

Unlock unlimited access to all IAM content